JP6963999B2 - セグメント細菌のインビトロ培養法 - Google Patents

セグメント細菌のインビトロ培養法 Download PDF

Info

Publication number
JP6963999B2
JP6963999B2 JP2017534355A JP2017534355A JP6963999B2 JP 6963999 B2 JP6963999 B2 JP 6963999B2 JP 2017534355 A JP2017534355 A JP 2017534355A JP 2017534355 A JP2017534355 A JP 2017534355A JP 6963999 B2 JP6963999 B2 JP 6963999B2
Authority
JP
Japan
Prior art keywords
sfb
strain
culture
cells
vitro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017534355A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018505666A (ja
JP2018505666A5 (cg-RX-API-DMAC7.html
Inventor
エバール,ジェラール
ビカール,ダヴィド
シュヌフ,パメラ
ベンスーサン,ナディーヌ セルフ
ガボリオ−ルティオ,ヴァレリー
サンソネッティ,フィリップ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique - Hôpitaux de Paris
Université Paris Descartes
Fondation Imagine
Institut Pasteur
Original Assignee
Assistance Publique - Hôpitaux de Paris
Université Paris Descartes
Fondation Imagine
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Assistance Publique - Hôpitaux de Paris, Université Paris Descartes, Fondation Imagine, Institut Pasteur filed Critical Assistance Publique - Hôpitaux de Paris
Publication of JP2018505666A publication Critical patent/JP2018505666A/ja
Publication of JP2018505666A5 publication Critical patent/JP2018505666A5/ja
Application granted granted Critical
Publication of JP6963999B2 publication Critical patent/JP6963999B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/23—Gastro-intestinal tract cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2017534355A 2014-12-23 2015-12-23 セグメント細菌のインビトロ培養法 Active JP6963999B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IBPCT/IB2014/067285 2014-12-23
PCT/IB2014/067285 WO2016103005A1 (en) 2014-12-23 2014-12-23 Method of culturing segmented filamentous bacteria in vitro
PCT/IB2015/059948 WO2016103217A1 (en) 2014-12-23 2015-12-23 Method of culturing segmented filamentous bacteria in vitro

Publications (3)

Publication Number Publication Date
JP2018505666A JP2018505666A (ja) 2018-03-01
JP2018505666A5 JP2018505666A5 (cg-RX-API-DMAC7.html) 2018-09-20
JP6963999B2 true JP6963999B2 (ja) 2021-11-10

Family

ID=52462962

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017534355A Active JP6963999B2 (ja) 2014-12-23 2015-12-23 セグメント細菌のインビトロ培養法

Country Status (6)

Country Link
US (2) US10435665B2 (cg-RX-API-DMAC7.html)
EP (1) EP3237602B1 (cg-RX-API-DMAC7.html)
JP (1) JP6963999B2 (cg-RX-API-DMAC7.html)
CN (1) CN107429222B (cg-RX-API-DMAC7.html)
AU (1) AU2015370419B2 (cg-RX-API-DMAC7.html)
WO (2) WO2016103005A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016103005A1 (en) * 2014-12-23 2016-06-30 Institut Pasteur Method of culturing segmented filamentous bacteria in vitro
CN106011281B (zh) * 2016-07-19 2019-04-23 浙江大学 肠道分节丝状菌鞭毛蛋白的检测方法
DE102018213030A1 (de) * 2018-08-03 2020-02-06 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Behandlung von Immunerkrankungen durch die antikörpervermittelte Neutralisierung spezifischer Darmbakterien
WO2021155229A1 (en) * 2020-01-31 2021-08-05 Iowa State University Research Foundation, Inc. Gut bacterium-based treatment to increase poultry gut health and food safety
CA3218163A1 (en) 2021-05-17 2022-11-24 Anne PALERMO Food product comprising a co-culture of bacteria and fungi
WO2026011048A1 (en) * 2024-07-03 2026-01-08 Ohio State Innovation Foundation Commensal bacterial antigen as a therapeutic agent for cancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120276149A1 (en) * 2009-10-15 2012-11-01 Dan Littman Methods for modulating bacterial infection
EP2556835B1 (en) * 2010-02-10 2015-08-05 Japan Eco-Science Co. Ltd. Mixture, dissolving solution and pharmaceutical agent each comprising thermophilic microorganism
MX369877B (es) 2013-02-04 2019-11-25 Seres Therapeutics Inc Composiciones y metodos.
WO2016103005A1 (en) * 2014-12-23 2016-06-30 Institut Pasteur Method of culturing segmented filamentous bacteria in vitro

Also Published As

Publication number Publication date
JP2018505666A (ja) 2018-03-01
US20170335276A1 (en) 2017-11-23
EP3237602B1 (en) 2020-06-10
AU2015370419B2 (en) 2021-12-23
WO2016103005A1 (en) 2016-06-30
WO2016103217A1 (en) 2016-06-30
EP3237602A1 (en) 2017-11-01
US20190367867A1 (en) 2019-12-05
CN107429222B (zh) 2021-06-15
CA2971933A1 (en) 2016-06-30
US11725183B2 (en) 2023-08-15
AU2015370419A1 (en) 2017-08-03
CN107429222A (zh) 2017-12-01
US10435665B2 (en) 2019-10-08

Similar Documents

Publication Publication Date Title
US11826424B2 (en) Compositions and methods for induction of Th17 cells
US11725183B2 (en) Method of culturing segmented filamentous bacteria in vitro
RU2546251C2 (ru) Пробиотический штамм бифидобактерий
CN108676774B (zh) 诱导调节性t细胞的增殖或积累的人源细菌
EP2238238B1 (en) Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process of manufacturing and uses thereof
CN108728473A (zh) 一种表达幽门螺杆菌NapA蛋白的重组载体、重组菌株及其制备方法、应用
CA3031379A1 (en) Postbiotic-based composition for treatment of ocular inflammation
CA2971933C (en) Method of culturing segmented filamentous bacteria in vitro
US20060240038A1 (en) Cells used as carriers for bacteria
KR102727571B1 (ko) 신규한 미생물 및 이를 포함하는 조성물
Kim et al. In vivo and in silico characterization of Lactobacillus reuteri SKKU-OGDONS-01, a potential probiotic from chicken intestine
CN100350038C (zh) 表达绿色荧光蛋白的乳酸杆菌基因工程体
HK1234318A1 (en) Compositions and methods for induction of th17 cells
HK1234318B (en) Compositions and methods for induction of th17 cells
Vizoso Pinto Molecular and physiological studies on the functionality of probiotic lactobacilli
HK1091726A (en) Cells used as carriers for bacteria

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180808

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180808

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190820

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20191118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200120

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200623

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200918

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200924

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210216

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210615

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210615

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20210629

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210622

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20210802

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20210803

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210928

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20211018

R150 Certificate of patent or registration of utility model

Ref document number: 6963999

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250